Annual short term debt:
$210.66M+$193.22M(+1107.79%)Summary
- As of today (September 17, 2025), PCRX annual short term debt is $210.66 million, with the most recent change of +$193.22 million (+1107.79%) on December 31, 2024.
- During the last 3 years, PCRX annual short term debt has fallen by -$171.93 million (-44.94%).
- PCRX annual short term debt is now -44.94% below its all-time high of $382.59 million, reached on December 31, 2021.
Performance
PCRX Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$212.02M+$526.00K(+0.25%)Summary
- As of today (September 17, 2025), PCRX quarterly short term debt is $212.02 million, with the most recent change of +$526.00 thousand (+0.25%) on June 30, 2025.
- Over the past year, PCRX quarterly short term debt has increased by +$202.87 million (+2217.38%).
- PCRX quarterly short term debt is now -44.58% below its all-time high of $382.59 million, reached on December 31, 2021.
Performance
PCRX quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
PCRX Short term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1107.8% | +2217.4% |
| 3 y3 years | -44.9% | +405.9% |
| 5 y5 years | +4168.8% | +2682.4% |
PCRX Short term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.9% | +1107.8% | at high | +2217.4% |
| 5 y | 5-year | -44.9% | +4168.8% | -44.6% | +2744.0% |
| alltime | all time | -44.9% | >+9999.0% | -44.6% | >+9999.0% |
PCRX Short term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $212.02M(+0.2%) |
| Mar 2025 | - | $211.49M(+0.4%) |
| Dec 2024 | $210.66M(+1107.8%) | $210.66M(+0.0%) |
| Sep 2024 | - | $210.66M(+2202.5%) |
| Jun 2024 | - | $9.15M(-48.1%) |
| Mar 2024 | - | $17.64M(+1.2%) |
| Dec 2023 | $17.44M(-59.2%) | $17.44M(+1.0%) |
| Sep 2023 | - | $17.27M(-39.4%) |
| Jun 2023 | - | $28.48M(+43.8%) |
| Mar 2023 | - | $19.80M(-53.7%) |
| Dec 2022 | $42.77M(-88.8%) | $42.77M(+1.3%) |
| Sep 2022 | - | $42.24M(+0.8%) |
| Jun 2022 | - | $41.91M(-79.2%) |
| Mar 2022 | - | $201.70M(-47.3%) |
| Dec 2021 | $382.59M(+143.6%) | $382.59M(+136.7%) |
| Sep 2021 | - | $161.63M(+1.4%) |
| Jun 2021 | - | $159.32M(+1.4%) |
| Mar 2021 | - | $157.15M(+0.0%) |
| Dec 2020 | $157.07M(+3082.8%) | $157.07M(+2006.9%) |
| Sep 2020 | - | $7.46M(-2.2%) |
| Jun 2020 | - | $7.62M(+92.0%) |
| Mar 2020 | - | $3.97M(-19.6%) |
| Dec 2019 | $4.93M(+1360.1%) | $4.93M(-2.1%) |
| Sep 2019 | - | $5.04M(-18.3%) |
| Jun 2019 | - | $6.17M(+10.5%) |
| Mar 2019 | - | $5.58M(+1551.8%) |
| Dec 2018 | $338.00K(+4.3%) | $338.00K(+1.2%) |
| Sep 2018 | - | $334.00K(+1.2%) |
| Jun 2018 | - | $330.00K(+0.9%) |
| Mar 2018 | - | $327.00K(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $324.00K(>+9900.0%) | $324.00K(+1.3%) |
| Sep 2017 | - | $320.00K(+0.3%) |
| Jun 2017 | - | $319.00K(-58.0%) |
| Mar 2017 | - | $759.00K(>+9900.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2016 | - | $107.56M(+1.1%) |
| Jun 2016 | - | $106.39M(+1.1%) |
| Mar 2016 | - | $105.22M(-0.7%) |
| Dec 2015 | $104.04M(+0.6%) | $105.93M(+1.0%) |
| Sep 2015 | - | $104.91M(+1.0%) |
| Jun 2015 | - | $103.89M(-0.2%) |
| Mar 2015 | - | $104.14M(+0.7%) |
| Dec 2014 | $103.38M(+3.4%) | $103.38M(+0.7%) |
| Sep 2014 | - | $102.67M(+0.8%) |
| Jun 2014 | - | $101.90M(+0.8%) |
| Mar 2014 | - | $101.06M(+1.1%) |
| Dec 2013 | $99.98M(>+9900.0%) | $99.98M(+1.1%) |
| Sep 2013 | - | $98.87M(>+9900.0%) |
| Jun 2013 | - | $891.00K(+4.5%) |
| Mar 2013 | - | $853.00K(+3.6%) |
| Dec 2012 | $823.00K(-90.0%) | $823.00K(-1.7%) |
| Sep 2012 | - | $837.00K(-28.1%) |
| Jun 2012 | - | $1.16M(-55.0%) |
| Mar 2012 | - | $2.58M(-68.7%) |
| Dec 2011 | $8.26M(+73.6%) | $8.26M(+34.0%) |
| Sep 2011 | - | $6.16M(-2.6%) |
| Jun 2011 | - | $6.33M(-11.9%) |
| Mar 2011 | - | $7.19M(+51.1%) |
| Dec 2010 | $4.76M(+197.5%) | $4.76M(+189.2%) |
| Sep 2010 | - | $1.65M |
| Dec 2009 | $1.60M | - |
FAQ
- What is Pacira BioSciences, Inc. annual short term debt?
- What is the all time high annual short term debt for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual short term debt year-on-year change?
- What is Pacira BioSciences, Inc. quarterly short term debt?
- What is the all time high quarterly short term debt for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly short term debt year-on-year change?
What is Pacira BioSciences, Inc. annual short term debt?
The current annual short term debt of PCRX is $210.66M
What is the all time high annual short term debt for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual short term debt is $382.59M
What is Pacira BioSciences, Inc. annual short term debt year-on-year change?
Over the past year, PCRX annual short term debt has changed by +$193.22M (+1107.79%)
What is Pacira BioSciences, Inc. quarterly short term debt?
The current quarterly short term debt of PCRX is $212.02M
What is the all time high quarterly short term debt for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly short term debt is $382.59M
What is Pacira BioSciences, Inc. quarterly short term debt year-on-year change?
Over the past year, PCRX quarterly short term debt has changed by +$202.87M (+2217.38%)